AI rivals back DNA rules to limit bioweapons risk in rare show of unity

Executives from leading AI companies have joined biotechnology experts in an urgent call to mandate safety screening for synthetic DNA purchases. In a public letter addressed to the US Congress, the signatories argue that rapid advances in AI could increase the risk of biological weapons being developed.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.